We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Highlights: COVID-19 home confinement of children is associated with up to 3X increase in prevalence of myopia in children 6 to 8 years old 18 months into the global COVID-19 Pandemic, VTI...
Data shows that patients with > +1.75 ADD power and above age 55 achieved vision comparable to spectacle acuity at every distance with NaturalVue Multifocal1 US-based medical device company...
Poster illustrates the Uninterrupted Plus Power Curve in the Central Optic Zone US-based medical device company and manufacturer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses...
Craig Johnson joined Visioneering Technologies, Inc. in the role of Quality Specialist, based in their Alpharetta, GA Headquarters. Johnson will be responsible for ongoing management of field...
Please replace the release dated July 31, 2019, with the following version due to additional information. US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal...
To ensure its valued customers receive the best service possible Visioneering Technologies Inc. (VTI), announced today that experienced sales executive Suzette Tineo has joined VTI as a Territory...
US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘the Company’) is...
US-based medical device company Visioneering Technologies Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) is pleased to announce that it has received the Award of Excellence for its innovative...
As the company continues its expansion, Visioneering Technologies Inc. (VTI), has announced the promotion of Cynthia Flynn to Senior Territory Manager in the Austin and San Antonio markets. This...
As the company continues its expansion, Visioneering Technologies Inc. (VTI), has announced that experienced sales executive Mat Hamilton has joined VTI as the Executive Territory Manager to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.001 | -1.96078431373 | 0.051 | 0.051 | 0.039 | 286833 | 0.04162551 | DE |
4 | -0.09 | -64.2857142857 | 0.14 | 0.14 | 0.039 | 187725 | 0.05138839 | DE |
12 | -0.07 | -58.3333333333 | 0.12 | 0.145 | 0.039 | 86602 | 0.05629765 | DE |
26 | -0.095 | -65.5172413793 | 0.145 | 0.15 | 0.039 | 53627 | 0.06754617 | DE |
52 | -0.195 | -79.5918367347 | 0.245 | 0.27 | 0.039 | 45115 | 0.10177687 | DE |
156 | -0.835 | -94.3502824859 | 0.885 | 1.05 | 0.039 | 30212 | 0.23831087 | DE |
260 | 0.001 | 2.04081632653 | 0.049 | 1.39 | 0.011 | 1029618 | 0.02743054 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions